Balaxi Pharmaceuticals Ltd.
Snapshot View

586.55 -14.90 ▼-2.5%

30 July 2021, 03:49:41 P.M.
Volume: 5,892

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.balaxipharma.in
Financial Indicators
Market Cap 586.55 Cr.
Earnings per share (EPS) 40.15 Trailing Twelve Months Ending 2021-06
Price-Earning Ratio (PE) 14.61 Trailing Twelve Months Ending 2021-06
Industry PE 117.83 Trailing Twelve Months Ending 2021-06
Book Value / Share 76.60 Trailing Twelve Months Ending 2021-06
Price to Book Value 7.66 Calculated using Price: 586.55
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.00 Cr. 10,000,000 Shares
FaceValue 10
Company Profile
Balaxi Pharmaceuticals Limited is a branded IPR-based pharmaceutical Company focusing on frontier markets, with a vast and growing portfolio of drugs across multiple therapeutic segments. Its markets extend across the continents of Americas, Africa and the Caribbean islands. It is a dynamic and responsible company, with a rich and growing portfolio of branded and generic medicines and consumer products.

Business area of the company

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products

History and Milestones

2003-07
  • Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.
  • Sourcing was from WHO GMP certified plants based in India.
2008-10
  • Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
2011-13
  • Started sourcing pharmaceutical from WHO GMP certified manufacturers in China by setting up an office in China in 2011.
  • Opened first wholesale depot for its ancillary business in Angola.
2014-16
  • In 2014, the group expanded its pharmaceutical business in Angola by setting up its 12th wholesale depot and a central distribution warehouse.
  • Made in-roads in Dominican Republic pharmaceutical market, submitted technical dossiers for securing product registrations and opened a central distribution warehouse.
2017-19
  • Set-up central distribution warehouse in Guatemala marking the entry of Balaxi into its third geography.
  • Leveraged the vast on-ground infrastructure in Angola by entering branded consumer goods products business in 2019.
2020
  • Submitted several technical dossiers of Pharmaceutical products in EL Salvador and Honduras for product registrations.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-2.48%
1 Week
-5.24%
1 Month
-0.19%
3 Month
+0.31%
6 Month
+11.26%
1 Year
+149.60%
2 Year
+762.57%
5 Year
+2706.46%
2 years 2019-03 2020-03
Return on Equity (%) 55.84 39.04
Return on Capital Employed (%) 69.35 57.07
Return on Assets (%) 32.19 29.01

Balance Sheet View Details

Particulars 2 years 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 4 28
Non Curr. Liab.
Curr. Liab. 3 8
Minority Int.
Equity & Liab. 6 36
Non Curr. Assets 0 1
Curr. Assets 6 35
Misc. Exp. not W/O
Total Assets 6 36

Profit Loss View Details

Particulars 2 years 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 14 46
Other Income 1 3
Total Income 14 48
Total Expenditure -12 -40
PBIDT 2 9
Interest 0
Depreciation 0
Taxation 0 -3
Exceptional Items
PAT 2 6

Cash Flow View Details

Particulars 2 years 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. -2 -14
Cash Fr. Inv. 0 0
Cash Fr. Finan. 18
Net Change -2 4
Cash & Cash Eqvt 0 4

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 73.23 72.86 72.86 72.86 72.86 72.86 72.86 72.86 72.86
Public 26.77 27.14 27.14 27.13 27.14 27.15 27.13 27.14 27.14
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Fri, 30 Jul 2021
Copy of Newspaper Publication
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication
Fri, 30 Jul 2021
Shareholders meeting
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25, 2021
Fri, 23 Jul 2021
Certificate under SEBI (Depositories and Participants) Regulations, 2018
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Technical Scans View Details

Fri, 30 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month
Stock Underperforming Sectoral Index in both 1 Week and 3 Month Stock Underperforming Sectoral Index in both 1 Week and 3 Month
Decreasing Relative Strength - Benchmark index Decreasing Relative Strength - Benchmark index
Decreasing Relative Strength - Sectoral index Decreasing Relative Strength - Sectoral index
Both SRS And ARS Below Zero Both SRS And ARS Below Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 156,272.01 1,420.90 +1.4%
Adani Transmission Ltd. 99,395.34 903.75 -4.1%
Sundram Fasteners Ltd. 16,089.53 765.70 +2.4%
Redington (India) Ltd. 12,783.63 327.30 +0.7%
MMTC Ltd. 7,567.50 50.45 -0.4%
Novartis India Ltd. 2,368.71 960.15 +2.2%
MSTC Ltd. 1,999.71 284.05 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 169.37 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 81.20 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 44.80 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 16.90 327.30 +0.7%
MMTC Ltd. Standalone 2020-12 0.00 50.45 -0.4%
Novartis India Ltd. Standalone 2021-03 113.34 960.15 +2.2%
MSTC Ltd. Consolidated 2021-03 17.70 284.05 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 9.11 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 16.32 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 6.86 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 2.59 327.30 +0.7%
MMTC Ltd. Standalone 2020-12 7.49 50.45 -0.4%
Novartis India Ltd. Standalone 2021-03 3.33 960.15 +2.2%
MSTC Ltd. Consolidated 2021-03 3.58 284.05 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 4.89 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 0.29 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 0.09 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 4.23 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 0.00 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 0.55 284.05 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 22.81 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 16.70 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 17.02 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -20.23 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 1.36 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 23.14 284.05 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 7.88 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 10.89 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 17.31 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 21.81 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -2.16 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 4.73 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 22.93 284.05 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 9,926.33 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 3,644.29 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 26,304.71 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 438.25 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 1,231.40 284.05 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 1,289.57 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 362.71 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 786.61 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -220.48 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 10.08 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 99.71 284.05 -1.5%